Interview with Jitirto Kusnadi, President, Mersifarma
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Address: Wisma Tiara 4th Floor Jl. Raya Pasar Minggu Km. 18 No. 17 Jakarta Indonesia
Tel: +62 21 7987683
Web: http://www.mersifarma.com/
PT Mersifarma TM, better known as “Mersi’, was established in 1997. The company initially focused on the manufacturing of medicines to combat Neuro-Psychiatric, Psychosomatic and Mental Health Diseases. Today other important areas of healthcare in which Mersi is involved are Internal Medicine, Pulmonary Diseases, Obstetrics-Gynaecology, Neuro-surgery, Ear-Nose and Throat Diseases, Dentistry, and advanced antibiotic therapeutic agents.
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Pfizer has been one of the earliest believers in the Indonesian market, establishing its presence since 1969. As the number one MNC in Indonesia, how would you assess the current…
You have been working at Kalbe for 38 years, and as President Director for 11 years. What has it been like to see the firm transform from a company based…
Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its…
Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of further improvement. What is…
How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian…
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
IDS Distribution is part of an Asian, globe spanning Distribution Company. How does being part of a large, regionally specialized player help IDS Distribution in Indonesia? The company’s regional presence…
Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
See our Cookie Privacy Policy Here
